SV

Street Verdict

Analyst Scorecard

A record of what Deven Choksey said publicly, with the source. Not advice.

Pending — not yet graded
“Distinctly confident about the prospects of the pharma sector going forward, despite tariff turbulence. Indian companies are strategizing with specialty and complex generics, offering pricing power, and expanding their API business. Improving input cost scenarios are also leading to better margins in the current financial year, suggesting potential re-rating once tariff clarity emerges.”
Nifty PharmaBullishCalled 10 Jun 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Deven Choksey’s full track record